{"id":530994,"date":"2021-02-20T17:38:01","date_gmt":"2021-02-20T17:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=530994"},"modified":"2021-02-20T17:38:01","modified_gmt":"2021-02-20T17:38:01","slug":"global-mice-model-market-technology-trends-growth-supply-demand-and-research-methodology-by-emergen-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-mice-model-market-technology-trends-growth-supply-demand-and-research-methodology-by-emergen-research_530994.html","title":{"rendered":"Global Mice Model Market Technology, Trends, Growth, Supply Demand and Research Methodology by Emergen Research"},"content":{"rendered":"
Increasing demand for humanized mice prototypes and increasing use of mice models in the study of virology and contagious diseases are driving the mice model market.<\/p>\n<\/div>\n

Mice Model Market<\/strong><\/p>\n

The increasing acceptance of modern technology and practical solutions in the healthcare and pharmaceuticals industry for drug discovery and development has altered the dynamics of patient recovery. Mice models are increasingly being used in virology to test new drugs before recommending appropriate dosage to human beings. The global mice model market was valued at USD 1.22 Billion in 2019. With constant government support in conducting new medical trials, the market is expected to register USD 2.00 Billion by the end of the year 2027, expanding at a CAGR of 6.8%.<\/p>\n

Get your Sample Copy with TOC of the Report to understand the structure of the complete report@ <\/strong>https:\/\/www.emergenresearch.com\/request-sample\/457<\/strong><\/a><\/p>\n

Prominent Players Profiled in the Mice Model <\/strong>Market:<\/strong><\/p>\n

Envigo Ltd, TransViragen Inc., Charles River Laboratories International Inc., GenOway S.A., The Jackson Laboratory, Ozgene Pty Ltd, GVK Biosciences Private Limited, Taconic Biosciences Inc., Pharmaron, Inc., and Horizon Discovery Group plc.<\/p>\n

Market Drivers<\/strong><\/p>\n

With the increment in the number of chronic disease cases in many countries worldwide and the rising demand for humanized mice prototypes among the laboratories, the market is expected to propel extensively high. The introduction of personalized drugs manufactured by pharmaceutical labs to adhere to patients’ disease while keeping in mind the specific drugs that might cause harmful infection makes use of exceptionally bred mice that run through every phase of medicine development. The increasing use of mice models in virology and contagious diseases studies and the augmenting research and development activities in the biopharmaceutical sector is projected to further drive the market growth.<\/p>\n